Literature DB >> 29288383

Transcription Factors Regulating Embryonic Development of Pulmonary Vasculature.

Craig Bolte1,2, Jeffrey A Whitsett2,3, Tanya V Kalin2, Vladimir V Kalinichenko4,5,6.   

Abstract

Lung morphogenesis is a highly orchestrated process beginning with the appearance of lung buds on approximately embryonic day 9.5 in the mouse. Endodermally derived epithelial cells of the primitive lung buds undergo branching morphogenesis to generate the tree-like network of epithelial-lined tubules. The pulmonary vasculature develops in close proximity to epithelial progenitor cells in a process that is regulated by interactions between the developing epithelium and underlying mesenchyme. Studies in transgenic and knockout mouse models demonstrate that normal lung morphogenesis requires coordinated interactions between cells lining the tubules, which end in peripheral saccules, juxtaposed to an extensive network of capillaries. Multiple growth factors, microRNAs, transcription factors, and their associated signaling cascades regulate cellular proliferation, migration, survival, and differentiation during formation of the peripheral lung. Dysregulation of signaling events caused by gene mutations, teratogens, or premature birth causes severe congenital and acquired lung diseases in which normal alveolar architecture and the pulmonary capillary network are disrupted. Herein, we review scientific progress regarding signaling and transcriptional mechanisms regulating the development of pulmonary vasculature during lung morphogenesis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29288383     DOI: 10.1007/978-3-319-68483-3_1

Source DB:  PubMed          Journal:  Adv Anat Embryol Cell Biol        ISSN: 0301-5556            Impact factor:   1.231


  18 in total

Review 1.  Building and Regenerating the Lung Cell by Cell.

Authors:  Jeffrey A Whitsett; Tanya V Kalin; Yan Xu; Vladimir V Kalinichenko
Journal:  Physiol Rev       Date:  2019-01-01       Impact factor: 37.312

2.  The S52F FOXF1 Mutation Inhibits STAT3 Signaling and Causes Alveolar Capillary Dysplasia.

Authors:  Arun Pradhan; Andrew Dunn; Vladimir Ustiyan; Craig Bolte; Guolun Wang; Jeffrey A Whitsett; Yufang Zhang; Alexey Porollo; Yueh-Chiang Hu; Rui Xiao; Przemyslaw Szafranski; Donglu Shi; Pawel Stankiewicz; Tanya V Kalin; Vladimir V Kalinichenko
Journal:  Am J Respir Crit Care Med       Date:  2019-10-15       Impact factor: 21.405

3.  FOXF1 transcription factor promotes lung morphogenesis by inducing cellular proliferation in fetal lung mesenchyme.

Authors:  Vladimir Ustiyan; Craig Bolte; Yufang Zhang; Lu Han; Yan Xu; Katherine E Yutzey; Aaron M Zorn; Tanya V Kalin; John M Shannon; Vladimir V Kalinichenko
Journal:  Dev Biol       Date:  2018-08-25       Impact factor: 3.582

4.  Postnatal Alveologenesis Depends on FOXF1 Signaling in c-KIT+ Endothelial Progenitor Cells.

Authors:  Xiaomeng Ren; Vladimir Ustiyan; Minzhe Guo; Guolun Wang; Craig Bolte; Yufang Zhang; Yan Xu; Jeffrey A Whitsett; Tanya V Kalin; Vladimir V Kalinichenko
Journal:  Am J Respir Crit Care Med       Date:  2019-11-01       Impact factor: 21.405

5.  Genome Editing for Rare Diseases.

Authors:  Arun Pradhan; Tanya V Kalin; Vladimir V Kalinichenko
Journal:  Curr Stem Cell Rep       Date:  2020-07-07

6.  Nanoparticle Delivery of Proangiogenic Transcription Factors into the Neonatal Circulation Inhibits Alveolar Simplification Caused by Hyperoxia.

Authors:  Craig Bolte; Vladimir Ustiyan; Xiaomeng Ren; Andrew W Dunn; Arun Pradhan; Guolun Wang; Olena A Kolesnichenko; Zicheng Deng; Yufang Zhang; Donglu Shi; James M Greenberg; Alan H Jobe; Tanya V Kalin; Vladimir V Kalinichenko
Journal:  Am J Respir Crit Care Med       Date:  2020-07-01       Impact factor: 21.405

7.  In Vivo Generation of Lung and Thyroid Tissues from Embryonic Stem Cells Using Blastocyst Complementation.

Authors:  Bingqiang Wen; Enhong Li; Vladimir Ustiyan; Guolun Wang; Minzhe Guo; Cheng-Lun Na; Gregory T Kalin; Veronica Galvan; Yan Xu; Timothy E Weaver; Tanya V Kalin; Jeffrey A Whitsett; Vladimir V Kalinichenko
Journal:  Am J Respir Crit Care Med       Date:  2021-02-15       Impact factor: 21.405

Review 8.  Therapeutic Potential of Endothelial Progenitor Cells in Pulmonary Diseases.

Authors:  Olena A Kolesnichenko; Jeffrey A Whitsett; Tanya V Kalin; Vladimir V Kalinichenko
Journal:  Am J Respir Cell Mol Biol       Date:  2021-11       Impact factor: 6.914

Review 9.  Nanoparticle Delivery Systems with Cell-Specific Targeting for Pulmonary Diseases.

Authors:  Zicheng Deng; Gregory T Kalin; Donglu Shi; Vladimir V Kalinichenko
Journal:  Am J Respir Cell Mol Biol       Date:  2021-03       Impact factor: 6.914

10.  Nanoparticle Delivery of STAT3 Alleviates Pulmonary Hypertension in a Mouse Model of Alveolar Capillary Dysplasia.

Authors:  Fei Sun; Guolun Wang; Arun Pradhan; Kui Xu; Jose Gomez-Arroyo; Yufang Zhang; Gregory T Kalin; Zicheng Deng; Ronald J Vagnozzi; Hua He; Andrew W Dunn; Yuhua Wang; Allen J York; Rashmi S Hegde; Jason C Woods; Tanya V Kalin; Jeffery D Molkentin; Vladimir V Kalinichenko
Journal:  Circulation       Date:  2021-06-11       Impact factor: 39.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.